Core Viewpoint - Kaixin Holdings has signed a term sheet to acquire a 51% stake in Honglu Technology, aiming to enhance collaboration in the "AI + Animation" ecosystem and promote AI innovation in animation production [1] Company Overview - Kaixin Holdings is transitioning into an AI-driven technology business in China, focusing on expanding its AI capabilities and exploring new growth opportunities [6] - Honglu Technology specializes in animation technology innovation, including the shift from traditional animation to computer-generated graphics, and utilizes emerging technologies such as rendering and AI research [2] Strategic Advantages of Honglu Technology - **Technical Advantage**: Comprehensive coverage of the 3D animation production process, utilizing UE5 Unreal Engine and AI technology R&D capabilities [3] - **Team Advantage**: The core team has over 10 years of industry experience and has produced nearly 5,000 hours of S-rated anime series [3] - **Content Sources Advantage**: Strategic partnerships with Youku Entertainment and suppliers of high-quality S-rated anime series [4] - **IP Advantage**: Ownership of original and novel copyright IP, a large fan base, and the ability to generate diverse derivative products [4] - **Qualifications Advantage**: Registered 19 software patents, showcasing strong technical capabilities in animation and design [4] - **Network Advantage**: Deep partnerships with Xuanji Technology and major video platforms like Youku, Tencent, and iQiyi, creating a robust ecosystem [4] Recent Developments - The previously intended acquisition of Xingcan was terminated as it did not meet mutual expectations, allowing Kaixin to focus on optimizing AI application scenarios [5]

WATERTOWN, Mass., Oct. 28, 2025 (GLOBE NEWSWIRE) -- Kymera Therapeutics, Inc. (NASDAQ: KYMR), a clinical-stage biopharmaceutical company advancing a new class of oral small molecule degrader medicines for immunological diseases, will report third quarter 2025 financial results on November 4, 2025. The Company will host a video conference call and webcast at 8:30 a.m. ET that day. To join the video call or view the livestreamed webcast, please register via this link, or visit “News and Events” in the Investo ...

LOS ANGELES, Oct. 28, 2025 (GLOBE NEWSWIRE) -- EVgo Inc. (Nasdaq: EVGO), one of the nation’s largest providers of public fast charging infrastructure for electric vehicles (EVs), today announced that it will release its third quarter 2025 financial results on Monday, November 10. This release will be followed by a webcast hosted by members of the EVgo management team at 8 a.m. ET (5 a.m. PT). EVgo Third Quarter 2025 WebcastWhen: Monday, November 10Time: 8 a.m. ET (5 a.m. PT)Live Webcast: https://investors.e ...

Core Points - Stella-Jones Inc. will hold an investor day on November 20, 2025, for institutional investors and research analysts in Toronto, Ontario [1] - The event will start at 9 a.m. EST and conclude at 12 p.m. EST, with limited in-person attendance by invitation only [2] - Virtual attendance is available via a provided link, and attendees are encouraged to join at least 10 minutes early [2] - An investor presentation will be available on the Company's website on the morning of the event, with a replay of the webcast accessible afterward [3] Company Overview - Stella-Jones Inc. is a leading North American manufacturer focused on infrastructure products essential for electrical distribution, transmission, and railway transportation systems [4] - The Company supplies treated wood and steel utility poles, steel lattice towers, and treated wood railway ties to major electrical utilities and railway operators in North America [4] - Stella-Jones also manufactures industrial products such as timbers for railway bridges and marine pilings, and distributes premium treated residential lumber to Canadian and American retailers [4]

Bolsters Wafer-Scale Test and Validation Capabilities and Supports Go-to-Market StrategyGOLETA, Calif., Oct. 28, 2025 (GLOBE NEWSWIRE) -- Aeluma, Inc. (NASDAQ: ALMU), a semiconductor company specializing in high-performance, scalable technologies for mobile, AI, defense and aerospace, robotics, automotive, AR/VR, and quantum computing, today announced that it has acquired significant capital equipment assets from a major components and solutions supplier to expand its prototyping and wafer-scale test capabi ...

Nutriband met with US FDA to obtain feedback on the Chemistry, Manufacturing, and Controls plans for AVERSA™ FENTANYL (abuse deterrent transdermal system) through commercialization. Nutriband received final meeting minutes from FDA and is incorporating the feedback into the development program as it moves forward to an IND filing in support of a Human Abuse Potential (HAP) clinical study for the product. ORLANDO, Fla., Oct. 28, 2025 (GLOBE NEWSWIRE) -- Nutriband Inc. (NASDAQ:NTRB)(NASDAQ:NTRBW), a company e ...

AC Immune Appoints Renowned Neurologist Catherine Mummery as Chair of Clinical Advisory Board Brings substantial expertise in development of first-in-class disease-modifying therapies in dementia across multiple novel modalitiesIncludes immunotherapies and small molecule drugs targeting intracellular proteinopathiesLeadership in groundbreaking early-stage clinical trials reinforces Company’s competencies Lausanne, Switzerland, October 28, 2025 -- AC Immune SA (NASDAQ: ACIU), a clinical-stage biopharmaceut ...

NEW YORK, Oct. 28, 2025 (GLOBE NEWSWIRE) -- Prospect Capital Corporation (NASDAQ: PSEC) (“Prospect”, “our”, or “we”) announced today that Prospect priced an institutional offering of approximately $167 million in aggregate principal amount of 5.5% Series A Notes due 2030 (the “Notes”) on October 27, 2025. “We appreciate the strong support and interest we received from over 40 institutional investors for this oversubscribed unsecured bond offering,” said Grier Eliasek, President of Prospect. “This leverage n ...

CHASKA, Minn. and TORRANCE, Calif., Oct. 28, 2025 (GLOBE NEWSWIRE) -- Lifecore Biomedical, Inc. (NASDAQ: LFCR) (“Lifecore”), a fully integrated contract development and manufacturing organization (“CDMO”), and PolyPeptide Laboratories, Inc. (“PolyPeptide”), a global leader in peptide contract development and manufacturing, today announced the signing of a collaboration agreement aimed at providing an integrated, end-to-end solution for peptide-based pharmaceutical customers in the U.S. The collaboration wil ...

Core Insights - Celestica Inc. has announced the reappointment of Laurette T. Koellner to its Board of Directors, enhancing the board's expertise and diversity [1][2] - Koellner's return is seen as timely for Celestica as the company aims to expand its competitive advantage in the technology sector [2] Company Overview - Celestica is a global leader in data center infrastructure and advanced technology solutions, focusing on AI, cloud, and hybrid cloud markets [3] - The company provides design, engineering, manufacturing, supply chain, and platform solutions to help customers achieve competitive advantages [3]